| Literature DB >> 35023933 |
Hua Zou1, Yan Shen1, Chunli Li1, Qiuhong Li1.
Abstract
PURPOSE: Severe infection has been the leading causes of neonatal death, especially the emergency of multidrug-resistant bacteria such as carbapenem-resistant Enterobacteriaceae. This study aimed to investigate the outbreak of carbapenem-resistant Klebsiella pneumoniae (CR-KP) in neonatal wards and to explore the possible pathogenesis of Klebsiella pneumoniae.Entities:
Keywords: NDM-1; carbapenem-resistant-Klebsiella pneumoniae; neonates; virulence
Year: 2022 PMID: 35023933 PMCID: PMC8748007 DOI: 10.2147/IDR.S343292
Source DB: PubMed Journal: Infect Drug Resist ISSN: 1178-6973 Impact factor: 4.003
General Characteristics and Antimicrobial Susceptibility of CR-KP Isolates
| Strains | Source | Minimum Inhibitory Concentration (μg/mL) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IMP | ETP | MEM | FEP | CRO | CAZ | ATM | AMC | TZP | Amk | Gen | Fos | TEC | COL | ||
| CR-KP01 | Secretion | >512 | >512 | 128 | >512 | >512 | >512 | >64 | >64 | >128 | 2 | 16 | 4 | >8 | ≤0.5 |
| CR-KP02 | Sputum | >512 | >512 | 128 | >512 | >512 | >512 | >64 | >64 | >128 | 2 | ≤2 | 4 | >8 | ≤0.5 |
| CR-KP03 | Sputum | >512 | >512 | 128 | >512 | >512 | >512 | >64 | >64 | >128 | 2 | ≤2 | 4 | >8 | ≤0.5 |
| CR-KP04 | Blood | >512 | >512 | 128 | >512 | >512 | >512 | >64 | >64 | >128 | 2 | ≤2 | 4 | >8 | ≤0.5 |
| CR-KP05 | Blood | >512 | >512 | 128 | >512 | >512 | >512 | >64 | >64 | >128 | 2 | ≤2 | 4 | >8 | ≤0.5 |
| CR-KP06 | Blood | >512 | >512 | 128 | >512 | >512 | >512 | >64 | >64 | >128 | 2 | ≤2 | 4 | >8 | ≤0.5 |
| CR-KP07 | Blood | >512 | >512 | 128 | >512 | >512 | >512 | >64 | >64 | >128 | 2 | ≤2 | 4 | >8 | ≤0.5 |
| CR-KP08 | Urine | >512 | >512 | 128 | >512 | >512 | >512 | >64 | >64 | >128 | 2 | ≤2 | 4 | >8 | ≤0.5 |
| CR-KP09 | Sputum | >512 | >512 | 128 | >512 | >512 | >512 | >64 | >64 | >128 | 2 | ≤2 | 4 | >8 | ≤0.5 |
| CR-KP10 | Sputum | >512 | >512 | 128 | >512 | >512 | >512 | >64 | >64 | >128 | 2 | ≤2 | 4 | >8 | ≤0.5 |
| CR-KP11 | Catheter | >512 | >512 | 128 | >512 | >512 | >512 | >64 | >64 | >128 | 2 | ≤2 | 4 | >8 | ≤0.5 |
| CR-KP12 | Catheter | >512 | >512 | 128 | >512 | >512 | >512 | >64 | >64 | >128 | 2 | ≤2 | 4 | >8 | ≤0.5 |
| CR-KP13 | Secretion | >512 | >512 | 128 | >512 | >512 | >512 | >64 | >64 | >128 | 2 | ≤2 | 4 | >8 | ≤0.5 |
| CR-KP14 | Blood | >512 | >512 | 128 | >512 | >512 | >512 | >64 | >64 | >128 | 2 | ≤2 | 4 | >8 | ≤0.5 |
| Type I | Blood | >512 | >512 | 128 | >512 | >512 | >512 | >64 | >64 | >128 | 2 | ≤2 | 4 | >8 | ≤0.5 |
| Type II | Blood | >512 | >512 | 128 | >512 | >512 | >512 | >64 | >64 | >128 | 2 | ≤2 | 4 | >8 | ≤0.5 |
Abbreviations: CAZ, ceftazidime; CRO, ceftriaxone; FEP, cefepime; ETP, ertapenem; IPM, imipenem; MEM, meropenem; TZP, piperacillin tazobactam; TC, tigecycline; COL, colistin; FOS, fosfomycin; LEV, levofloxacin; CIP, ciprofloxacin; AMK, amikacin; GEN, gentamicin; TEC, tigecycline; COL, colistin.
Figure 1PFGE dendrogram of CR-KP isolates from March, 2017 to February, 2019. All the strains were divided into three clusters. Cluster A belongs to ST147, Clusters B belongs to 3444 and Clusters C belongs to ST17.
Figure 2Biofilm formation and serum complement-mediated killing of selected CR-KP isolates. (A) Biofilm formation of CR-KP 01 belongs to ST17, CR-KP 14 belongs to ST147 and CR-KP 02 belongs to ST3444. (B) Serum complement-mediated killing of selected CR-KP isolates.
Figure 3Virulence potential of K. pneumoniae strains in a Galleria mellonella infection model. (A) The survival rate of G. mellonella infected with CR-KP 01inoculum of 1×108 CFU/mL, 1×106 CFU/mL and 1×104 CFU/mL. (B) The survival rate of G. mellonella infected with CR-KP 14 inoculum of 1×108 CFU/mL, 1×106 CFU/mL and 1×104 CFU/mL. (C) The survival rate of G. mellonella infected with CR-KP 02 inoculum of 1×108 CFU/mL, 1×106 CFU/mL and 1×104 CFU/mL.
Figure 4The characteristics of type I and Type II. (A) PFGE dendrogram of these two types. (B) Biofilm formation of type I and Type II. (C) Serum complement-mediated killing of these two types. (D) Virulence potential of type I and Type II in a Galleria mellonella infection model.
Figure 5The transcriptomes of type I and Type II. (A) Histogram presentation of GO classification. M: Cell wall/membrane/envelope biogenesis; N: Cell motility; O: Posttranslational modification, protein turnover, chaperones; U: Intracellular trafficking, secretion, and vesicular transport; K: Transcription; L: Replication, recombination and repair; C, Energy production and conversion; E: Amino acid transport and metabolism; F: Nucleotide transport and metabolism; G: Carbohydrate transport and metabolism; H: Coenzyme transport and metabolism; I: Lipid transport and metabolism; P: Inorganic ion transport and metabolism; Q: Secondary metabolites biosynthesis, transport and catabolism; S: Function unknown; The y-axis indicates the number of genes in each category. (B) COG functional classification of type I and Type II.
Figure 6KEGG pathway analysis of type I and Type II. A total of 115 DEGs were assigned to 41 KEGG pathways. KEGG pathway analysis showed that 10 pathways were obviously changed (P-value <0.05) in theType I. Arginine and proline metabolism, fatty acid degradation, geraniol degradation and phosphotransferase system were overexpressed in type I.